Recombinant Human Complement Component C1rLP His Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 11614-CP

HA-tag His-tag
R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
11614-CP-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

  • R&D Systems CHO-derived Recombinant Human Complement Component C1rLP His Protein (11614-CP)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession #

NP_057630.1

Conjugate

Unconjugated

Applications

Binding Activity

View all Complement Component C1rLP Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human Complement Component C1rLP protein
Cys36-Asp487 with N-terminal HA (YPYDVPDYA) and 6-His tags

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Tyr

Predicted Molecular Mass

52 kDa

SDS-PAGE

70-76 kDa, under reducing conditions

Activity

Measured by its ability to cleave a colorimetric peptide substrate, N-carbobenzyloxy-Gly-Arg-ThioBenzyl ester (Z-GR-SBzl), in the presence of 5,5’Dithio-bis (2-nitrobenzoic acid) (DTNB). Edwards, K.M. et al. (1999) J. Biol. Chem. 274:30468.
The specific activity is >30 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Human Complement Component C1rLP His Protein, CF

Recombinant Human Complement Component C1rLP HA-tag His-tag Protein Enzyme Activity.

Recombinant Human Complement Component C1rLP HA-tag His-tag (Catalog # 11614-CP) is measured by its ability to cleave a colorimetric peptide substrate, N-carbobenzyloxy-Gly-Arg-ThioBenzyl ester (Z-GR-SBzl), in the presence of 5,5’Dithio-bis (2-nitrobenzoic acid) (DTNB).

Recombinant Human Complement Component C1rLP HA-tag His-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Human Complement Component C1rLP HA-tag His-tag Protein (Catalog # 11614-CP) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 70-76 kDa, under reducing conditions.

Formulation, Preparation and Storage

11614-CP
Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Complement Component C1rLP

Recombinant human Complement C1r subcomponent-like protein (C1rLP), also known as C1r-like serine protease analog protein (CLSPa) is a 487 residue glycosylated, secreted serine peptidase-like protein (1, 2).  It contains an N-terminal signal peptide, a CUB domain for substrate and protein-protein interaction, a truncated complement control protein module, and a trypsin-like serine protease domain with a characteristic catalytic triad but lacks an activation consensus peptide and an EGF domain found in homologous complement cascade proteases like C1r protein (1, 2). It is broadly expressed and secreted in tissues and abundantly found in liver, kidney, and myeloid cells where significant expression of serine proteases typically occurs (1). C1rLP has esterolytic activity on peptide thioesters with arginine at the P1 position but lower catalytic efficiency compared to C1r (2). It was reported to mediate cleavage of haptoglobin (3) and subsequently proposed to be of use in hemoglobin-binding therapeutics (4). Complement cascade serine proteases such as C1r play a role in innate immunity but the role of C1rLP in complement-mediated function is unclear as both activation and inhibition roles have been described in the literature (1, 2). C1rLP has been shown to be a pathological marker in immune microenvironments including within acute myocardial infarction and COVID19 as well as several types of cancer such as colon, leukemia, brain, endometrial, and melanoma (5-12). As a pathological marker, it has also been proposed as a potential therapeutic target for the treatment of these diseases (12).

References

  1. Lin, N. et al. (2004) Biochem. Biophys. Res. Commun. 321:329.
  2. Ligoudistianou, C. et al. (2005) Biochem. J. 387:165.
  3. Wicher, K.B. et al. (2004) Proc. Natl. Acad. Sci. 101:14390.
  4. Schaer, C.A. et al. (2018) BMC Biotechnol. 18:15. 
  5. Liu, X. et al. (2021) ACS Omega 6:7951.
  6. Yang, S. et al. (2022) Front. Oncol. 12:934928.
  7. Chen J. et al. (2023) Aging 15:4444.
  8. Njoku K. et al. (2023) Br. J. Cancer 128:1723.
  9. Yoon, H.G. et al. (2023) PLoS One 18:e0295061.
  10. Beck. H.C. et al. (2024) Int. J. Mol. Sci. 25:2638.
  11. Liu, G. et al. (2024) Heliyon 11:e32337.
  12. Zhang, M. et al. (2024) Heliyon 10:e30616.

Long Name

Complement C1r Subcomponent-like Protein

Alternate Names

C1RL, C1RL1, CLSPa

Entrez Gene IDs

51279 (Human); 232371 (Mouse)

Gene Symbol

C1RL

UniProt

NP_057630.1

Additional Complement Component C1rLP Products

Product Documents for Recombinant Human Complement Component C1rLP His Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Complement Component C1rLP His Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.